Ayurvedic treatment outcome for Chronic Liver diseases

Dr. Ashok Kumar Panda; Dr. K. K. Rath

doi:10.21760/jaims.v4i06.785

Dr. Ashok Kumar Panda Research Officer (Ayurveda), Central Ayurveda Research Institute of Hepatobiliary disorders, Bharatpur, Near Kaliga Studio, Bhubaneswar, Odisha, INDIA.
Dr. K. K. Rath Research Officer (Ayurveda), Central Ayurveda Research Institute of Hepatobiliary disorders, Bharatpur, Near Kaliga Studio, Bhubaneswar, Odisha, INDIA. A unit of CCRAS, M/O AYUSH, GOI.

DOI: https://doi.org/10.21760/jaims.v4i06.785

Keywords: CLD, Cirrhosis, ALD, DILI, NAFLD, NASH, Kamala, Halimaka, Panaki, Yakrit Suska, Yakrit Vidradhi (Liver Abcess), Yakrit Granthi ( Liver cyst), Yakrit Dalludara, Krimija Yakruit Roga

Abstract

Currently available medical therapies for liver disorders have more systemic toxicity, cost effective and liver transplantation was advised to many cases. So many patients want to take ayurveda medication as last choice or as a choice due to poverty. We have documented more than 200 cases and found 40% cases are Non Alcoholic Fatty liver diseases followed by Cirrhosis of liver. There are more than three hundred herbo-mineral preparations in Ayurveda system of medicine for the treatment of jaundice and chronic liver diseases. More than 50% people of our country relay on Ayurveda and herbal medicine for liver diseases. Ayurveda medicine could represent a promising tool to postpone the need of liver transplantations, increase the QoL of patients with cirrhosis, and reduce overall treatment costs of Chronic liver diseases. Ayurveda also delivered sodhana ( Purificatory treatment) by means of Panchakarma treatment. Rasayana therapy is very helpful in CLD. Diet has a integral role in Outcome of a CLD patient. Evidences are coming for remission of hepatao-cellular carcinoma and reversal of fibrosis of liver with high life expectancy. So public participation as well as awareness for Ayurveda treatment in Chronic liver diseases are required. Proper training and modern skill development should be mandatory for of Ayurveda Physicians treating liver diseases . More evidences in terms of Ayurveda outcome studies are the need of the hour to create a hope for CLD Patients.

Downloads

Download data is not yet available.

References

Mukherjee PS, Vishnubhatla S, Amarapurkar DN, Das K, Sood A, Chawla YK, et al. (2017) Etiology and mode of presentation of chronic liver diseases in India: A multi centric study. PLoS ONE 12(10): e0187033. https://doi.org/10.1371/journal.pone.0187033

Panda AK, Bhuyan GC, Rao MM (2017) Ayurvedic Intervention for Hepatobiliary Disorders: Current Scenario and Future Prospect. J Tradit Med Clin Natur 6: 210.

Philips C A, Augustine P, Paramaguru R, et al. (February 22, 2019) Ayurveda Herbal Medicine-induced Liver Cirrhosis. Cureus 11(2): e4122. doi:10.7759/cureus.4122

Philips CA, Paramaguru R, Joy AK, Antony KL, Augustine P. Clinical outcomes, histopathologic patterns and chemical analysis of ayurveda and herbal medicine associated with severe liver injury—a single center experience from South India. Indian J Gastroenterol. 2018; 37: https://doi.org/10.1007/s12664-017-0815-8.

Luper S (1998) A review of plants used in the treatment of liver disease: part 1.Alter Med Rev 36: 410-421.

Del Prete A, Scalera A, Iadevaia MD, Miranda A, Zulli C, et al. (2012) Herbal Products: Benefits, Limits, and Applications in Chronic Liver Disease. Evid Based Compl Alter Med 2012

Panda, Ashok Kumar et al. Phyto Extracts of Carica Papaya and Tinospora Cordifolia can correct Thrombocytopenia In Alcoholic Decompensate Liver Cirrhosis : Case Series. Journal of Ayurveda and Integrated Medical Sciences (ISSN 2456-3110), http://www.jaims.in/index.php/jaims/pages/view/Citation, v. 3, n. 1, p. 99 - 101, apr. 2018. ISSN 2456-3110.

Ravirajsinh Jadeja, Ranjitsinh V. Devkar, and Srinivas Nammi, “Herbal Medicines for the Treatment of Nonalcoholic Steatohepatitis: Current Scenario and Future Prospects,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 648308, 18 pages, 2014. https://doi.org/10.1155/2014/648308.

Panda AK, Das D, Dixit AK, Hazra J (2015) Rapid clearance of HbsAg and liver transaminase in hepatitis B infection with classical Ayurvedic formulation: case study. Asian J Phytomed Clin Res 3: 1-5.

Panda AK, Rath KK, Barik LD (2016) Survival outcome in the patients with advanced hepato-celluar carcinoma treated with Ayurveda medication: Case series. Proceeding of World Ayurveda congress.

Ashok Kumar Panda , Fiboscan evidence of Reversal of Liver fibrosis by Ayurveda Medication: Case series, Journal of Clinical and Experimental Hepatology, Volume 8,

Poornima P, Efferth T (2016) Ayurveda for Cancer Treatment. Med Aromat Plants (Los Angel) 5: e178. doi: 10.4172/2167-0412.1000e178

Nishanta Shukla , Ayurvedic approach for management of liver parenchymal disease: A case study,5th World Congress on Hepatitis & Liver Diseases Proceeding , August 10-12, 2017 London, UK.